Keynote speaker on global trends, author of 16 Futurist books - Patrick Dixon.
Future Health Care and Pharma Keynote Speaker
Latest news summary - exelon and other treatments.
Exelon was launched in 1997 as a treatment for Alzheimer's disease, and received regulatory approval for Europe in May 1998 - but does it work? Novartis says it delays the process by around six months. Now Novartis want to conduct larger studies, having shown that the drug seems to slow down progression in some people in earlier trials of 3,300 people.
Read more: Alzheimer's disease - Exelon may slow illness
Future Health Care and Pharma Keynote Speaker
Infertility clinics have become big business over the last two decades with 20% IVF growth every year, but the technology has sometimes failed to deliver as patients expect with big variations in success rates between different clinics. Explore this busy IVF site for more - many pages and video.
Read more: The truth about IVF treatment - Future Health
Future Health Care and Pharma Keynote Speaker
Interferon b helps Multiple Sclerosis. Natalizumab slows down MS attacks
Interferon b treatment helps multiple sclerosis recovery and survival. That's according to the Interferon b PRISMS study by Dr George Ebers, Division of Neurology, London Health Sciences Centre Ontario in the Lancet (7 November 1998).
Read more: New hope for multiple sclerosis - Interferon B
Future Health Care and Pharma Keynote Speaker
About 16 million men worldwide have taken Viagra. As of September 2001, 640 deaths were reported worldwide - but how many were actually caused by Viagra? Pfizer sales of Viagra are $1.5bn a year.
Read more: Viagra - 6,000 headlines in 12 months